Swati Gupta

Biography

Swati Gupta provides expertise in integrating scientific initiatives and leveraging innovation for improved synergy and learning across IAVI’s R&D portfolio. Previously, she was an Executive Director with Merck Vaccines, where she worked on the development of innovative partnership models to address cross-cutting issues related to vaccine science and technology. As part of this role, she worked with key external stakeholders to facilitate accelerated Ebola vaccine development efforts to enhance preparedness for the ongoing public health crisis and for potential future outbreaks. From 2000 to 2014, Gupta was in the Department of Epidemiology at Merck Research Laboratories where she led a number international, prospective cohort studies in support of vaccine and infectious disease products in development, including research on diseases such as HIV, HPV, influenza, dengue, and C.difficile. From 1998 to 2000, Dr. Gupta worked as a scientist in HIV Surveillance at the Communicable Disease Surveillance Centre (British equivalent of the US CDC) in the UK. She has also worked at the Bureau of Tuberculosis Control at the New York City Department of Health. Gupta holds a doctorate in epidemiology from the Johns Hopkins Bloomberg School of Public Health and a master’s of public health infectious disease epidemiology from Yale University School of Medicine.  

Research Interest

vaccine and infectious disease products in development, including research on diseases such as HIV, HPV, influenza, dengue, and C.difficile.